Clinical Development Director, Oncology Clinical Operations Asset Lead

Site Name: USA - Pennsylvania - Upper Providence, Canada - Ontario - Mississauga, GSK House, UK - Hertfordshire - Stevenage, USA - Massachusetts - Waltham
Posted Date: Apr 11 2023
GSK site preferred locations: Upper Providence – Collegeville, PA; Waltham, MA; Mississauga, Canada; Stevenage, UK; GSK House, UK. On-site presence of 2-3 days per week average is required.

• New GSK UK Headquarters - move from GSK House, Brentford **

We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.
Closing Date for Applications: April 20th, 2023 (COB)
Please take a copy of the , as this will not be available post closure of the advert.
The Clinical Operations Asset Lead represents all Clinical Operations functions at the asset level and is accountable for developing the operational strategy and delivery plan to execute the scientific strategy for an asset and associated studies, working in partnership with clinical / biostats / clinical supplies and the functional subject matter experts to ensure informed asset decision-making from the operational, scientific and data perspectives
This role will provide you the opportunity to:

• Utilises lessons learnt and prior experiences to ensure best practises and strategies.
• Provides input into the overarching Clinical Development Plan and the development of studies that align to the Clinical Development Plan and are feasible to implement in the clinical and regulatory environment of participating regions, to provide quality data and ensure timely study delivery, coordinating expert inputs from clinical and non-clinical functions.
• Contribution to the development of the Clinical Development Plan and Integrated Evidence Plan, during Research, Development phases of the asset lifecycle.
• Be part of the protocol development finalisation and subsequent amendments including relevant review boards/committees to ensure operational feasibility and consistency within the asset.

• Approves/endorses assessment, selection, contracting and management of appropriate vendors for outsourced clinical activities and services, ensuring compliance with GSK standards.
• Resourcing strategy
• Leads resourcing discussions and accountable for the final strategy (in vs outsourcing) for the asset, and studies, in accordance with the resourcing strategy & principles.

• Ensure regular interaction with clinical operations functions involved in the asset such that they are aware of issues, risks and successes with study delivery as they occur.
• Oversight of delivery quality
• Responsible for the coordination and leadership of cross-functional team input into development plans, ensuring quality delivery of all studies included within the plans.
• For outsourced programs coordinate oversight to ensure the quality delivery by provider.
• Ensure clinical operations inspection readiness at all times and supports preparations in the event that any studies within the asset is subject to inspection.
• Lead escalation point from study and asset level to raise and assist with issues on behalf of the team, including serious quality incidents and serious breaches of GCP.

• Drives innovative approaches to study execution through external facing advances in technology and sciences, by identifying and embracing risks and opportunity
• Accountability for budget forecasts for future interventional clinical and Epi studies and Clinical Operations asset level costs, ensuring they are accurately represented and managed in financial tools
• Part of the clinical file submission team coordinating deliveries linked to interventional clinical and Epi studies and responses to questions raised by Health Authorities on operational activities. Responsible to deliver applicable operational modules for the file.
• To ensure clinical operational delivery with a collaborative partner in a co-development environment
• Delivery plan
• Model scenarios for optimal asset/study delivery linked to value drivers and drives decisions presented to governance boards to optimise delivery with transparent implications to time, quality, risks resources and budget.
• Accountability for asset delivery strategy (e.g. country, diversity, patient engagement strategies etc) in collaboration with cross-functional stakeholders, with particular accountability for Clinical Operations contributions to governance boards
• Accountable for the operational planning, feasibility and delivery of their assigned asset(s) and associated Development Plan(s), on time and on budget, from beginning to end whilst optimizing time and cost efficiency, including resource utilization.

• Accountable for translating technical content to ensure appropriate operational implementation at the study level
• Accountable for all data related to delivery strategy (e.g. country footprint, resourcing strategy) is accurate and contemporaneous in GSK systems (including clinical trial tracking systems).
• Accountable for asset level mitigation plans are implemented to avoid and manage risk/quality issues
• Ensure asset level operational risk management plan is in-place and applies a smart-risk taking philosophy
• Asset level risk register, communication, and systems data
• Manages internal and external stakeholders through appropriate engagement and communication

Capabilities:

• Innovative and change adept whilst identifying and embracing risks as opportunities
• Excellent influencing and stakeholder management skills at all levels of the organization.
• Excellent leadership skills building and managing matrixed teams, promoting motivation and empowerment of others to accomplish individual, team and organizational objectives
• To be an external advocate, representing GSK at congresses, industry bodies or other external opportunities
• Partnering skills with key role such as clinical science, biostatistics and other subject matter experts (SME) at asset level to articulate and champion key decisions and strategy
• Demonstrates conceptual, analytical and strategic thinking to innovative approaches to clinical delivery, leverage external technology and networks and build internal capability
• Highly developed communication skills appropriate to the target audience, promoting effective decision-making
• Ability to translate strategic concepts, scientific requirements, stakeholder feedback and expectations into cohesive actions for the Asset team
• Ability to represent the function in change initiatives or SME roles, embracing and promoting GSKs’ values and culture
• Competent in working with complexity and uncertainty within the external regulatory environment (e.g. FDA, EMEA)
• Ability to effectively prioritize activities and stakeholder needs whilst balancing the broader business needs with the needs of their specific asset
• Ability to establish and build internal and external relationships at all levels in a highly dynamic and matrixed environment, demonstrating conflict management and negotiation skills
• Ability to define value-driven vision and roadmap for the Clinical and or Epi Development Plan

Why you?
Basic Qualifications:
We are looking for professionals with these required skills to achieve our goals:

• Leadership experience with senior stakeholder management.
• Experience in study and matrix management is required.
• Bachelor’s in general science or Life/Health related Science Degree required.
• 12 years of significant experience in managing clinical research projects.
• At least 5 years of oncology clinical operations experience

Preferred Qualifications:
If you have the following characteristics, it would be a plus:

• 10+ years of oncology clinical operations experience

Why GSK?
We’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.
In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.
Find out more:
Our approach to R&D.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.